Oragenics Inc (NYSE MKT LLC:OGEN)

Data as of Jan 23
 -0.0496 / -5.98%
Today’s Change
Today|||52-Week Range
Health Technology

Company Description

Oragenics, Inc. is a biopharmaceutical company, which is focused on oral probiotics products and novel antibiotics for humans and companion pets. It also develops, markets and sells proprietary probiotics designed to enhance oral health for humans and pets under Evora and ProBiora brand names. Oragenics was founded by Jeffrey D. Hillman and Robert T. Zahradnik in November 1996 and is headquartered in Tampa, FL.

Contact Information

Oragenics, Inc.
4902 Eisenhower boulevard
Tampa Florida 33634
P:(813) 286-7900
Investor Relations:



Other institutional9.88%
Individual stakeholders48.26%
Mutual fund holders3.91%

Top Executives

Michael O'Keefe SullivanCEO, CFO, Secretary & Treasurer
Martin HandfieldSenior Vice President-Discovery Research
Albert G. FosmoeSenior VP-Operations & Product Development
Guojun NieDirector-Process Development

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2015 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2015. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2015 and/or its affiliates.